POLICY BRIEFINGS
Recently Introduced Health Legislation Cont. 3
S.64 — A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products; Sponsor: Sen. Klobuchar, Amy [D-MN]; Committees: Senate – Judiciary
S.68 — A bill to require the Medicaid and CHIP Payment and Access Commission to publish an annual report on the estimated impact in each State of the Medicaid expansion added by the Patient Protection and Affordable Care Act, including the estimated impact that adopting such expansion would have in States that have not expanded their Medicaid coverage; Sponsor: Sen. Jones, Doug [D-AL]; Committees: Senate – Finance
H.R.366 — To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program; Sponsor: Rep. Rush, Bobby L. [D-IL-1]; Committees: House - Energy and Commerce, Ways and Means
H.R.373 — To amend title XVIII of the Social Security Act to provide for certain administrative or judicial review respecting the identification of primary care practitioners under part B of the Medicare program; Sponsor: Rep. Brownley, Julia [D-CA-26]; Committees: House - Energy and Commerce, Ways and Means
H.R.383 — To amend the Patient Protection and Affordable Care Act to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited; Sponsor: Rep. Joyce, David P. [R-OH-14]; Committees: House - Energy and Commerce
S.73 — A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs; Sponsor: Sen. Shaheen, Jeanne [D-NH]; Committees: Senate – Finance
S.80 — A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; Sponsor: Sen. Barrasso, John [R-WY]; Committees: Senate – Finance
S.95 — A bill to amend the Public Health Service Act to designate certain medical facilities of the Department of Veterans Affairs as health professional shortage areas, and for other purposes; Sponsor: Sen. Klobuchar, Amy [D-MN]; Committees: Senate - Health, Education, Labor, and Pensions
S.97 — A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals; Sponsor: Sen. Sanders, Bernard [I-VT]; Committees: Senate - Health, Education, Labor, and Pensions
S.99 — A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes; Sponsor: Sen. Sanders, Bernard [I-VT]; Committees: Senate – Finance
S.102 — A bill to significantly lower prescription drug prices for patients in the United States by ending governmentgranted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries; Sponsor: Sen. Sanders, Bernard [I-VT]; Committees: Senate - Health, Education, Labor, and Pensions
S.105 — A bill to amend title X of the Public Health Service Act to prohibit family planning grants from being awarded to any entity that performs abortions, and for other purposes; Sponsor: Sen. Blackburn, Marsha [R-TN]; Committees: Senate - Health, Education, Labor, and Pensions S.106 — A bill to reauthorize and extend funding for community health centers and the National Health Service Corps; Sponsor: Sen. Blunt, Roy [R-MO]; Committees: Senate – Finance
H.R.437 — To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes; Sponsor: Rep. Sensenbrenner, F. James, Jr. [R-WI-5]; Committees: House - Energy and Commerce
H.R.447 — To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals; Sponsor: Rep. Cummings, Elijah E. [D-MD-7]; Committees: House - Energy and Commerce
H.R.448 — To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes; Sponsor: Rep. Cummings, Elijah E. [D-MD- 7]; Committees: House - Energy and Commerce, Ways and Means
H.R.456 — To amend the Patient Protection and Affordable Care Act to permit insurers to offer catastrophic coverage plans to anyone, and for other purposes; Sponsor: Rep. Fortenberry, Jeff [R-NE-1]; Committees: House - Energy and Commerce
H.R.457 — To amend the Internal Revenue Code of 1986 to increase the maximum contribution limit for health savings accounts, and for other purposes; Sponsor: Rep. Fortenberry, Jeff [R-NE-1]; Committees: House - Ways and Means
H.R.458 — To prohibit implementation of the revised definition of short-term, limited duration insurance in order to permit such insurance to provide up to 12 months of coverage; Sponsor: Rep. Fortenberry, Jeff [R-NE-1]; Committees: House - Energy and Commerce, Education and Labor, Ways and Means
H.R.460 — To amend title XIX of the Social Security Act to amend the Federal medical assistance percentage for the District of Columbia for fiscal years after 2020, and for other purposes; Sponsor: Rep. Griffith, H. Morgan [R-VA-9]; Committees: House - Energy and Commerce
H.R.461 — To amend the Public Health Service Act to ensure appropriate care by certain 340B covered entities for victims of sexual assault, and for other purposes; Sponsor: Rep. Griffith, H. Morgan [R-VA-9]; Committees: House - Energy and Commerce
H.R.465 — To significantly lower prescription drug prices for patients in the United States by ending governmentgranted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries; Sponsor: Rep. Khanna, Ro [D-CA-17]; Committees: House - Energy and Commerce, Judiciary
H.R.478 — To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada; Sponsor: Rep. Pingree, Chellie [D-ME-1]; Committees: House - Energy and Commerce
H.R.485 — To amend title 38, United States Code, to provide for the circumstances under which the Secretary of Veterans Affairs shall provide reimbursement for emergency ambulance services; Sponsor: Rep. Tipton, Scott R. [R-CO-3]; Committees: House - Veterans’ Affairs
January 14, 2019: | Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7
SERVICES
- Strategy & Planning
- Information & Counsel
- Washington Presence & Influence
- Materials Development
- Grassroots Advocacy
- Partnership & Coalition Building
- Communications
BRIEFING ARCHIVE
- 2023
- - November 2023
- 11/27/23 VIEW | PRINTABLE PDF
- 11/20/23 VIEW | PRINTABLE PDF
- 11/13/23 VIEW | PRINTABLE PDF
- 11/6/23 VIEW | PRINTABLE PDF
- + October 2023
- + September 2023
- + August 2023
- + July 2023
- + June 2023
- + May 2023
- + April 2023
- + March 2023
- + February 2023
- + January 2023